Related Experiment Video

Updated: Jun 1, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Effects of RhebL1 silencing on the mTOR pathway

Ashley Bonneau1, Nitika Parmar

  • 1Biology Program, California State University Channel Islands, 1 University Drive, Camarillo, CA 93012, USA.

Molecular Biology Reports
|June 10, 2011
PubMed

Insights

This study investigated RhebL1

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The insulin/Ras Homolog Enriched in Brain (Rheb)/Mammalian Target of Rapamycin (mTOR) pathway is crucial in cancer development.
  • mTOR pathway activation is regulated by the Rheb1 G-protein, with two mammalian Rheb genes: Rheb1 and RhebL1 (Rheb2).
  • The functional redundancy between Rheb1 and RhebL1 remains largely undetermined.

Purpose of the Study:

  • To investigate the specific contribution of RhebL1 to the mTOR pathway.
  • To determine if Rheb1 and RhebL1 possess redundant functions in regulating mTOR signaling.
  • To analyze the impact of RhebL1 gene silencing on mTOR pathway activity.

Main Methods:

  • Transient gene silencing of Rheb1 and RhebL1, individually and in combination, using eleven specific siRNAs.
  • Experiments conducted in HEK293, HeLa, and NIH3T3 cell lines.
  • Cross-reactivity assays confirmed the specificity of siRNA-mediated gene silencing for Rheb1 and RhebL1.

Main Results:

  • Rheb1 silencing significantly impacted mTOR pathway activity, evidenced by changes in S6 phosphorylation.
  • RhebL1 silencing did not affect S6 phosphorylation, indicating a distinct role compared to Rheb1.
  • This study provides the first examination of endogenous Rheb gene function using single and dual silencing strategies.

Conclusions:

  • RhebL1 does not appear to regulate the mTOR pathway through the same mechanism as Rheb1.
  • RhebL1 may influence the mTOR pathway via a mechanism distinct from Rheb1-mediated regulation.
  • Further research is warranted to elucidate the specific role and potential non-redundancy of RhebL1 in cellular signaling.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale10:56

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale

Published on: May 17, 2014

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...